2021 Investor Materials

Annual Report

View an enhanced version of our Annual Report.

View Document

Proxy Statement

View an enhanced version of our Proxy Statement.

View Document

Voting

Vote by phone by dialing
866-291-6836.

Vote Now

Request Paper Materials

Request paper copies of the above proxy materials online now, by email or by phone by
dialing 866-648-8133.

OnlineEmail

Annual Meeting

Note: You must register to participate in the meeting.

Register Online Now

Date

June 24, 2021

Time

3:30 PM ET

Who We Are

Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.

Visit www.flexiontherapeutics.com.

Powered by Donnelley Financial Solutions
Copyright © 2021 Mediant Communications Inc.
All Rights Reserved.